Abaxis (Abaxis) Insider Ownership : 6.87 % (As of May. 06, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Abaxis Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Abaxis's insider ownership is 6.87%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Abaxis's Institutional Ownership is 91.71%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Abaxis's Float Percentage Of Total Shares Outstanding is 67.06%.

Abaxis Insider Ownership Historical Data

The historical data trend for Abaxis's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Insider Ownership Chart

Abaxis Historical Data

The historical data trend for Abaxis can be seen below:

	2017-10-31	2017-11-30	2017-12-31	2018-01-31	2018-02-28	2018-03-31	2018-04-30	2018-05-31	2018-06-30	2018-07-31
Insider Ownership	6.62	6.64	6.64	6.60	6.60	6.46	6.46	7.14	6.87	6.87

Abaxis Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Abaxis (Abaxis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.abaxis.com

Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.

Executives

Richard Bastiani	director	C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr	officer: CFO and VP of Finance	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson	director, officer: CEO & Board Chairman	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey	director	ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020